^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

WT1 expression

i
Entrez ID:
Phase 1
3D Medicines
Active, not recruiting
Last update posted :
10/25/2023
Initiation :
08/01/2022
Primary completion :
05/01/2024
Completion :
12/01/2024
WT1
|
WT1 expression • WT1 positive
|
Zeltherva (galinpepimut-S)
Phase 1
Cue Biopharma
Recruiting
Last update posted :
09/27/2023
Initiation :
06/14/2022
Primary completion :
12/01/2024
Completion :
12/01/2026
WT1 • CTLA4
|
WT1 expression • WT1 positive
|
CUE-102
Phase 1
Memorial Sloan Kettering Cancer Center
Completed
Last update posted :
04/07/2023
Initiation :
04/01/2016
Primary completion :
04/06/2023
Completion :
04/06/2023
WT1 • MUC16 • CTAG1B
|
WT1 expression • CTAG1B expression • WT1 positive
|
Opdivo (nivolumab) • Zeltherva (galinpepimut-S)
Phase N/A
Sellas Life Sciences Group
Unknown status
Last update posted :
01/10/2020
Initiation :
04/01/2013
Primary completion :
06/01/2018
Completion :
08/01/2020
IFNG • WT1 • CD4
|
WT1 expression • WT1 positive
|
lenalidomide • bortezomib • Zeltherva (galinpepimut-S) • Leukine (sargramostim)
Phase 1/2
Ann & Robert H Lurie Children's Hospital of Chi...
Completed
Last update posted :
03/06/2017
Initiation :
07/01/2005
Primary completion :
06/01/2010
Completion :
01/01/2015
IFNG • TNFA • WT1 • IL2RA • CD4 • IL10 • IL4 • ISG20
|
WT1 expression • WT1 positive
|
fludarabine IV • busulfan